Literature DB >> 4117883

Further characterization of a factor from endotoxin-treated serum which releases histamine and heparin from mast cells.

W A Hook, R Snyderman, S E Mergenhagen.   

Abstract

Upon incubation of hamster serum with bacterial endotoxin, a factor is produced which releases histamine and heparin from hamster mast cells and increases capillary permeability in guinea pig skin. The major histamine-releasing activity derived from hamster serum was characterized by gel filtration, found to have a molecular weight of approximately 60,000, and shown by electrophoresis to migrate with alpha-2- or beta-1-globulins. The ability to increase vascular permeability was not reversed by antihistamine. On the basis of these properties, the histamine-liberating factor generated by endotoxin in hamster serum differed significantly from known anaphylatoxins.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4117883      PMCID: PMC422462          DOI: 10.1128/iai.5.6.909-914.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

Review 1.  BACTERIAL ENDOTOXEMIA.

Authors:  B W ZWEIFACH; A JANOFF
Journal:  Annu Rev Med       Date:  1965       Impact factor: 13.739

Review 2.  THE TISSUE MAST CELL.

Authors:  D E SMITH
Journal:  Int Rev Cytol       Date:  1963

3.  The release of histamine.

Authors:  W D PATON
Journal:  Prog Allergy       Date:  1958

4.  Interactions of the complement system with endotoxic lipopolysaccharide: the generation of an anaphylatoxin.

Authors:  L M Lichtenstein; H Gewurz; N F Adkinson; H S Shin; S E Mergenhagen
Journal:  Immunology       Date:  1969-03       Impact factor: 7.397

5.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

6.  HEPARIN ENHANCEMENT OF FACTORS STIMULATING BONE RESORPTION IN TISSUE CULTURE.

Authors:  P GOLDHABER
Journal:  Science       Date:  1965-01-22       Impact factor: 47.728

7.  Histamine-releasing factor generated by the interaction of endotoxin with hamster serum.

Authors:  W A Hook; R Snyderman; S E Mergenhagen
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

8.  Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.

Authors:  W D da Silva; J W Eisele; I H Lepow
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

9.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

10.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  5 in total

1.  Reactivity of mast cells to Mycoplasma salivarium.

Authors:  C F Parkinson
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

Review 2.  The effects of bacterial endotoxins on host mediation systems. A review.

Authors:  D C Morrison; R J Ulevitch
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

3.  Bronchial venular leakage during endotoxin shock.

Authors:  G G Pietra; J P Szidon; H A Carpenter; A P Fishman
Journal:  Am J Pathol       Date:  1974-12       Impact factor: 4.307

4.  Release of histamine from hamster mast cells by concanavalin A and phytohemagglutinin.

Authors:  W A Hook; S F Dougherty; J J Oppenheim
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

5.  Pathogenicity ofAeromonas hydrophila in red leg disease in frogs.

Authors:  M M Rigney; J W Zilinsky; M A Rouf
Journal:  Curr Microbiol       Date:  1978       Impact factor: 2.188

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.